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Background: To investigate the effect of 3 months of Tai Chi Chuan (TCC) training on heart rate variability,
blood lipids and cytokine production in elderly people.
Methods: This was a longitudinal study with 3 months of follow-up. Participants were recruited from the
community and divided randomly into two groups. The TCC trainees exercised the classical Yang’s TCC
for 40 minutes/session, seven times/week over a course of 3 months. Twenty-ﬁve TCC trainees (median
age¼ 57.0 years, range¼ 50.0e67.0 years) and 25 control individuals (median age¼ 53.0 years,
range¼ 46.5e58.5 years) were included in this study.
Results: TCC training for 3 months signiﬁcantly increased the fasting blood sugar (p< 0.001), ratio of
forced expiratory volume in the ﬁrst second to the forced vital capacity (FEV1/FVC) (p< 0.05), high-
density lipoprotein-cholesterol (HDL-C) (p< 0.05), tumor necrosis factor-a (TNF-a) (p< 0.001), and
interferon-g (IFN-g) (p< 0.001) in the TCC trainees. In contrast, the total cholesterol (TC) and the ratio of
TC to HDL-C (TC/HDL-C) of the TCC trainees were all signiﬁcantly decreased after 3 months of TCC
training (p< 0.001). However, all heart rate variability (HRV) measures were not signiﬁcantly changed
after 3 months of TCC.
Conclusion: Three months of TCC training can improve the pulmonary function, glucose availability and
blood lipid proﬁle, as well as increase the cytokine production, in middle-aged and elderly individuals.
TCC may be beneﬁcial to middle-aged and elderly people as a health-promoting calisthenics.
Copyright  2012, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Tai Chi Chuan (TCC) is a traditional oriental conditioning exer-
cise, or calisthenics, that is believed by many people around the
world to be good for the health. It has been estimated that there are
more than one hundred million TCC practitioners in the world1.
However, not many studies have examined the beneﬁcial effect of
TCC on the health of people who practice it on a regular basis. The
most popular reason as to why this particular merit is deserved is
that TCC improves cardiopulmonary function and immunity of
individuals who practice it continuously. For instance, TCC has been
shown to delay the decline of aerobic power2, improve the
cardiopulmonary function3,4, balance5 and strength4 of individuals.erest.
ry of Biophysics, Department
ospital, 201, Sec. 2, Shih-Pai
iwan Society of Geriatric EmergenGoulopoulou and colleagues pointed that a 16-week exercise
training program improved cardiac autonomic modulation in
response to an oral glucose load in obese adults, independently of
diabetes status, and in the absence of remarkable changes in body
weight, body composition, ﬁtness level, and glycemic control6.
Tumor necrosis factor (TNF) has been shown to be an independent
predictor of depressed heart rate variability (HRV) in patients with
heart failure7. The ability of long-term HRV parameters to better
reﬂect activation of diverse hormonal systems, may explain their
greater prognostic power for risk stratiﬁcation in patients with
congestive heart failure (CHF)8. A review paper showed that
research has demonstrated consistent, signiﬁcant results for
a number of health beneﬁts in randomized controlled trials,
evidencing progress towards recognizing the similarity and
equivalence of Qigong and Tai Chi9. Thus, it is worthwhile exam-
ining the effects of TCC on the HRV, blood lipid and cytokine
proﬁles of individuals who have practiced TCC for a certain period
of time.
Duration and vigor in keeping up sufﬁcient physical exercise are
widely considered as critical elements that may affect one’scy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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a 12-week program of regular TCC exercise, enhanced functional
mobility, personal health expectations, and regulatory T cell func-
tion10. Yeh et al have shown that by appropriately combining a TCC
exercise programwith diabetic medication, the glucosemetabolism
and immunity can be improved in type 2 diabetic patients11.
Therefore, the ﬁrst aim of this study was to examinewhether or not
TCC could change blood biochemistry and cytokine proﬁles in TCC
practitioners.
Hyperlipidemia has been shown to play a signiﬁcant role in the
pathogenesis of coronary artery disease, and the impact of physical
exercise on high-density lipoprotein (HDL) metabolism has been
recognized as a major mechanism involved in the reduction of the
risk of coronary artery disease. Jafari et al12 demonstrated that
exercise signiﬁcantly increases plasma pre-b HDL and decreases
plasma HDL-triglycerides. Hence, the second aim of this study was
to examine whether or not TCC could change the plasma lipid
proﬁle in TCC practitioners.
Vagal modulationwas found to be lower in various physiological
conditions. Such examples include aging13, pregnancy14, and
different recumbent positions15. Exercise is an effective physio-
logical means which can increase the vagal modulation of normal
individuals16. Thus, the third aim of this study, was to examine
whether or not TCC could increase the vagal modulation of TCC
practitioners.
2. Methods
2.1. Subjects
The elderly subjects who participated in this study were
volunteers who were recruited from the community through
a recruitment notice on a bulletin board of the hospital. They were
randomly allocated into either the control group or the study (TCC)
group. The method of randomization was implemented by
throwing a coin. All subjects included in this study were> 45 years
of age, had no previous experience with TCC, had normal lifestyles,
and were capable of daily activities without limitations. Individuals
who had major cardiopulmonary disease, or were on regular
medicine for diabetes mellitus, hypertension, renal or liver disease,
were not included in the study. The Institutional Review Board of
the hospital approved this study, the procedure was fully explained
to the volunteers, and signed, informed consent was obtained from
them prior to the study.
2.2. Equipment
Before measurements were taken, the participants took a rest in
the supine position for 5 minutes, before a train of electrocardio-
graphic (ECG) signals was recorded from lead II (Biochem Vital Sign
Monitor, BCI International, Waukesha, Wisconsin, USA) for 10
minutes. The resting standard 12-lead ECG and spirometry (IQmark
digital ECG and digital spirometer, Brentwood Medical Technology
Corp., Torrance, CA, USA), as well as arterial blood pressure
measurement (Kenlu-model K-300 sphygmomanometer, Di Tai
Precision Ent. Co., Ltd., Kaohsiung City, Taiwan) were performed on
both the controls and the TCC trainees before and after 3 months of
TCC. The sampling frequency for ECG recording was 200 Hz. Spiro-
metric data, such as forced vital capacity (FVC), the percentage of
forced vital capacity to predicted forced vital capacity (%FVC¼ FVC
of the participant/predicted FVC), forced expiratory volume in the
ﬁrst second (FEV1), the percentage of FEV1 (%FEV1¼ FEV1 of the
participant/predicted FEV1), and the ratio of FEV1 to FVC (FEV1/FVC),
as well as hemodynamic data such as systolic blood pressure (SBP),
diastolic blood pressure (DBP),mean arterial blood pressure (MABP),and pulse pressure (PP) were obtained from every participant in the
control group and TCC group before TCC training and after 3 months
of TCC training. The TCC trainees exercised TCC once/day for 3
months.
2.3. Study protocol
The individuals included in this study were requested to not
take any caffeinated or alcoholic beverages for at least 24 hours
prior to the study, and they were also requested to not exercise on
the day of study. The ECG recording, hemodynamic and spirometry
data were measured after the subject had rested quietly for 5
minutes, and then a blood sample was withdrawn for later assay.
After hemodynamic and spirometric measurements and ECG
recordings, the TCC trainees were advised to exercise the classical
Yang’s TCC for 40 minutes. Each session of Yang’s TCC included a 10
minute warm-up exercise (lower back and hamstring stretching,
gentle calisthenics, and balance training), a 20-minute TCC exercise,
and a 10-minute cool-down exercise. Each set of Yang’s TCC
consists of 64 successive postures1. While practicing TCC, the TCC
trainee kept the same pace in exercising the different postures of
TCC in a sequence according to a pre-recorded tape, to ensure that
the same pace and sequence of postures were followed. After 3
months of TCC training, which consisted of 40 minutes of exercise/
session, 7 times/week, a second ECG recording, hemodynamic
measurements and blood sampling were performed using the same
procedure. All procedures were performed in a bright and quiet
room with a standardized temperature of 24e25C and a stan-
dardized humidity of 54e55%.
2.4. Heart rate variability analysis
An R-wave detecting software was used to identify the peaks of
the R waves in the recorded ECG signals, and to measure the
consecutive RR intervals. Sinus pause and arterial or ventricular
arrhythmia were deleted and the last 512 stationary RR intervals in
each session were obtained for spectral HRV analysis.
The mean, standard deviation (SDRR) and coefﬁcient of variation
(CVRR) of the 512 stationary RR intervals were calculated using
standard formulae for each participant. The power spectra of RR
intervals were obtained by means of fast Fourier transformation
(Mathcad, Mathsoft Inc., Cambridge, MA, USA). The direct current
component was excluded before the calculation of individual
powers. The area under the spectral peaks within the range of
0.01e0.4 Hz, 0.01e0.04 Hz, 0.04e0.15 Hz, and 0.15e0.40 Hz were
deﬁned as the total power (TP), very low-frequency power (VLFP),
low-frequency power (LFP), and high-frequency power (HFP),
respectively. The normalized high-frequency power (nHFP¼HFP/
TP) was used as the index of vagal modulation; the normalized low-
frequency power (nLFP¼ LFP/TP) as the index of sympathetic and
vagal modulation; the low-/high-frequency power ratio (LFP/HFP)
as the index of sympathovagal balance17; and the normalized very
low frequency power (nVLFP¼VLFP/TP) as the index of vagal
withdrawal and renin-angiotensin-aldosterone system of the
subject18.
2.5. Biochemistry and cytokine analysis
The biochemistry assays for the quantitative measurements of
total cholesterol (TC) (Ektachem Clinical Chemistry Slides, Johnson
& Johnson Clinical Diagnostics, Rochester, NY), HDL-cholesterol
(HDL-C) (INTEGRA 700, Roche Diagnostics, Basel, Switzerland),
low-density lipoprotein-cholesterol (LDL-C) (INTEGRA 700, Roche
Diagnostics, Basel, Switzerland), triglyceride (TG), fasting blood
sugar (FBS), and uric acid (UA) (Ektachem Clinical Chemistry Slides,
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formed on blood samples obtained from each participant. The
immunoenzymometric assays for the quantitativemeasurement of
TNF-a (BioSource TNF-a EASIA kit, BioSource Europe S.A., Nivelles,
Belgium) and interferon-g (IFN-g) (BioSource IFN-g EASIA kit,
BioSource Europe S.A., Nivelles, Belgium) in the serum were also
performed on blood samples from each participant. After 3 months
of TCC training, spirometry, hemodynamic data, blood biochem-
istry, lipid proﬁle and serum cytokine levels of the TCC trainees
were measured using the same methodology.
2.6. Statistical analysis
The Mann-Whitney rank sum test (SigmaStat statistical soft-
ware, SPSS Inc., Chicago, IL, USA) was employed to compare general
characteristics, spirometry, hemodynamics, HRV measurements in
both time and frequency domains, blood biochemistry, lipid proﬁle
and serum cytokine levels between TCC trainees before TCC
training and the controls. The Wilcoxon signed rank test was per-
formed to compare the general characteristics, spirometry, hemo-
dynamics, HRV measures in both time and frequency domains,
blood biochemistry, lipid proﬁle and serum cytokine levels
between before TCC training and after 3 months of TCC training in
the TCC group. All data are presented as median (25%e75%). A p
value < 0.05 is considered statistically signiﬁcant.
To correct for the baseline differences in the comparisons of
general characteristics, spirometry, hemodynamics, HRV, blood
lipid and cytokine proﬁles between controls and TCC trainees, the
percentage changes in these parameters in each subject before and
after 3 months were calculated by using the following formula:
%X¼ [(XafterXbefore)/(Xbefore)] 100
where X¼ the parameter to be compared. The Mann-Whitney
rank sum test was utilized to compare %X between controls and
TCC trainees. A p value < 0.05 was considered statistically
signiﬁcant.
3. Results
3.1. General characteristics
Twenty-ﬁve TCC trainees (8 males, 17 females) and twenty-ﬁve
controls (12 males, 13 females) were included in this study. All TCCTable 1
General characteristics, spirometry and hemodynamics of controls and TCC trainees befo
Characteristics Controls (before 3 mo)
(n¼ 25)
Controls (after 3 mo)
(n¼ 25)
Age (y) 53 (47w 59) 53 (47w 59)
Gender (M/F) 12/13 12/13
Body weight (kg) 61 (53w 62) 61 (55w 63)
Body height (cm) 162 (158w 163) 162 (158w 163)
BMI (kg/m2) 22.9 (20.9w 24.9) 22.9 (21.4w 24.9)
FVC (L) 2.7 (2.3w 3.2) 2.6 (2.3w 3.2)
%FVC (%) 85.0 (77.0w 89.3) 85.0 (82.3w 87.5)
FEV1 (L) 2.3 (1.7w 2.5) 2.3 (1.7w 2.5)
%FEV (%) 82.0 (72.8w 89.3) 83.0 (72.8w 90.3)
FEV1/FVC (%) 80.0 (74.3w 84.5) 80.4 (75.4w 86.4)
SBP (mmHg) 119 (107w 128) 120 (113w137)
DBP (mmHg) 67 (61w 74) 67 (63w 72)
MABP (mmHg) 83 (77w 92) 85 (80w 92)
PP (mmHg) 48 (42w 56) 53 (43w 65)
Data are presented as medians (25 percentilew 75 percentile).
* p< 0.05 versus before TCC training in TCC trainees.
BMI¼ body mass index; DBP¼ diastolic blood pressure; FEV1¼ forced expiratory volu
pressure; PP¼ pulse pressure; SBP¼ systolic blood pressure.trainees received 3 months of Yang’s TCC training for 40 minutes/
day at 7:00 AM, 7 times/week. Table 1 tabulates the general char-
acteristics, spirometry and hemodynamics of the controls and TCC
trainees before and after the 3 months of TCC training. There were
no signiﬁcant differences in general characteristics, spirometry and
hemodynamics between the controls and TCC trainees before TCC
training. After 3 months of TCC training, the FEV1/ FVC increased
signiﬁcantly from 79.0% (75.0w 82.8%) to 81.0% (77.0w 85.0%), but
the FEV1/FVC before and after TCC was still within normal ranges.
3.2. Comparison of HRV measures before and after TCC training
Table 2 shows the time and frequency domains HRVmeasures of
the controls and TCC trainees before and after TCC training. There
was no signiﬁcant difference in the time and frequency domains
HRV measures between the controls and TCC trainees before
training. There was also no signiﬁcant difference in the time and
frequency domains HRV measures between TCC trainees before
training and after 3 months of TCC training, except that the high
frequency power (HFP) was increased signiﬁcantly after 3 months
of TCC training. It seems that the frequency domain HRV measures,
such as the high frequency power, were more sensitive than the
time domain HRV measures in the detection of change after 3
months of TCC training.
3.3. Changes in blood biochemistry, lipid proﬁle and cytokine levels
after TCC
Table 3 shows the changes in blood biochemistry, lipid proﬁle,
and cytokine levels after 3 months of TCC training. There were no
signiﬁcant differences in blood biochemistry, lipid proﬁle and UA
between the controls and TCC trainees before TCC training.
However, the TNF-a and IFN-g of TCC trainees before TCC training
were signiﬁcantly lower than those from the control group.
In the TCC group, the FBS was increased signiﬁcantly from
89.0 mg/dL (81.0w 93.8 mg/dL) before TCC training to 96.0 mg/dL
(92.5w104.0 mg/dL) after 3 months of TCC, and the HDL-C was
increased signiﬁcantly from 54.0 mg/dL (43.3w 64.0 mg/dL) before
TCC training to 55.0 mg/dL (45.3w 63.0 mg/dL) after 3 months of
TCC. By contrast, the TC was decreased signiﬁcantly from 206.0 mg/
dL (180.0w 235.0 mg/dL) before TCC training to 191.0 mg/dL
(164.5w 205.0 mg/dL) after 3 months of TCC. Because of the
increase in HDL-C and the decrease in TC, the ratio of TC over HDL-C
(TC/HDL-C) was signiﬁcantly decreased from 4.15 (3.46w 5.00)re and after TCC training.
TCC trainees (before training)
(n¼ 25)
TCC trainees (after training)
(n¼ 25)
57 (50w 67) 57 (50w 67)
8/17 8/17
56 (52w 63) 56 (52 w 63)
156 (153w 164) 156 (153w 164)
22.7 (21.6w 24.6) 22.6 (21.6w 24.5)
2.6 (2.2w 2.9) 2.5 (2.2w 2.9)
87.0 (79.3w 95.0) 86.0 (80.3w 90.3)
2.1 (1.7w 2.3) 2.1 (1.8w 2.4)
84.0 (77.5w 92.3) 86.0 (80.3w 91.5)
79.0 (75.0w 82.8) 81.0 (77.0w 85.0)*
126 (112w 131) 120 (109w 133)
67 (64w 69) 67 (60w 72)
85 (82w 92) 82 (78w 92)
55 (49w 65) 51 (44w 64)
me in the ﬁrst second; FVC¼ forced vital capacity; MABP¼mean arterial blood
Table 2
HRV measures of the controls and TCC trainees before and after TCC training.
Measures Controls (before 3 mo)
(n¼ 25)
Controls (after 3 mo)
(n¼ 25)
TCC Trainees (before training)
(n¼ 25)
TCC Trainees (after training)
(n¼ 25)
Time domain HRV measures
Mean RRI (ms) 884 (781w 938) 892 (791w 956) 921 (826w 1027) 891 (801w 957)
Heart rate (bpm) 67 (63w 75) 68 (65w 76) 65 (58w 73) 67 (63w 75)
SDRR (ms) 48 (37w 52) 43 (36w 50) 41 (28w 55) 34 (24w 50)
CVRR (%) 5.3 (3.6w 6.1) 5.1 (3.9w 6.2) 4.4 (3.1w 5.3) 3.7 (2.8w 5.3)
Frequency domain HRV measures
TP (ms2) 993 (634w 1176) 823 (583w 1202) 681 (371w 1312) 508 (215w 1455)
VLFP (ms2) 163 (115w 363) 195 (97w 359) 215 (140w 300) 148 (77w 355)
LFP (ms2) 268 (167w 318) 258 (148w 371) 157 (89w 322) 92 (53w 421)
HFP (ms2) 395 (249w 458) 319 (232w 491) 259 (117w 628) 305 (57w 436)*
nHFP (nu) 39.9 (32.9w 53.8) 44.3 (38.5w 51.6) 40.1 (23.9w 61.6) 39.7 (21.4w 56.3)
nLFP (nu) 29.2 (25.7w 33.2) 30.5 (26.9w 39.8) 23.7 (18.6w 29.2) 27.4 (20.7w 33.5)
nVLFP (nu) 22.9 (16.5w 34.2) 25.5 (18.5w 30.9) 31.3 (18.6w 46.0) 29.0 (23.2w 46.6)
LFP/HFP 0.80 (0.52w 1.13) 0.68 (0.51w 0.93) 0.54 (0.33w 1.49) 0.76 (0.44w 1.17)
Data are presented as medians (25 percentilew 75 percentile).
*p< 0.05 versus before TCC training.
CVRR¼ coefﬁcient of variation of RR; HFP¼ high-frequency power; LFP¼ low-frequency power; LFP/HFP¼ low-/high-frequency power ratio; nHFP¼ normalized high-
frequency power; nLFP¼ normalized low-frequency power; nu¼ normalized unit; nVLFP¼ normalized very low-frequency power; RRI¼ RR intervals; SDRR¼ standard
deviation of RR; TP¼ total power; VLFP¼ very low-frequency power.
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(p< 0.001). No signiﬁcant change in UA was observed after TCC
training in the TCC trainees.
For the serum cytokines, the TNF-a increased signiﬁcantly from
7.9 mg/mL (6.5w12.9 mg/mL) before TCC training to 16.2 mg/mL
(13.4w19.3 mg/mL) after 3 months of TCC; and the IFN-g was
increased signiﬁcantly from 0.38 mg/mL (0.32w 0.43 mg/mL) before
TCC training to 0.96 mg/mL (0.73w1.30 mg/mL) after 3 months of
TCC. The IFN-g after 3 months of TCC training was signiﬁcantly
higher than that before TCC training and the controls. Similarly, the
TNF-a after 3 months of TCC training was higher than that before
TCC training and the controls.
Table 4 shows the % change in general characteristics, spirom-
etry and hemodynamics of the controls and TCC trainees after 3
months of TCC. The % decreases in body weight and BMI after 3
months of TCC training in TCC traineeswere larger than those of the
controls 3 months after. By contrast, the % increases in FEV1 after 3
months of TCC training in TCC traineeswere larger than those of the
controls 3 months after. No signiﬁcant difference in the % change in
age, body height, FVC, %FVC, %FEV, FEV1/FVC, and hemodynamics 3
months after was found between the two groups. Table 5 shows the
% changes in HRV measures, blood biochemistry, lipid proﬁle and
cytokine levels in the controls and TCC trainees. The % decrease in
TC and TC/HDL-C after 3 months of TCC training in TCC trainees was
larger than those of the controls 3 months after. In contrast, the %Table 3
Changes in blood biochemistry, lipid proﬁle and cytokine levels before and after 3 mont
Blood tests Controls (before 3 mos)
(n¼ 25)
Controls (after 3 mo)
(n¼ 25)
FBS (mg/dL) 93 (83w 102) 97 (85w 105)
TG (mg/dL) 125 (89w 167) 117 (102w 136)
TC (mg/dL) 201 (185w 210) 198 (179w 211)
LDL-C (mg/dL) 125 (109w 152) 126 (109w 153)
HDL-C (mg/dL) 51 (48w 60) 52 (47w 63)
TC/HDL-C 3.98 (3.17w 4.46) 3.94 (3.08w 4.26)
LDL-C/HDL-C 2.36 (1.97w 2.88) 2.49 (1.99w 2.96)
UA (mg/dL) 5.9 (4.8w 6.5) 5.9 (5.0w 6.5)
TNF-a (mg/mL) 13.9 (12.7w 17.6) 14.4 (13.2w 17.5)
IFN-g (mg/mL) 0.47 (0.42w 0.60) 0.51 (0.45w 0.61)
Data are presented as medians (25 percentilew 75 percentile).
*p< 0.01 versus controls; Ap< 0.001 versus controls; #p< 0.05 versus before TCC traini
FBS¼ fasting blood sugar; HDL-C¼ high-density lipoprotein-cholesterol; HDL-C/TC¼ th
cholesterol; TG¼ triglycerides; TNF-a¼ tumor necrosis factor-alpha; IFN-g¼ interferon-increase in FBS, TNF-a and IFN-g after 3 months of TCC training in
the TCC trainees was larger than those controls 3 months after. No
signiﬁcant differences in the % change in HRV measures, TG, LDL-C,
HDL-C, LDL-C/HDL-C, and UA after 3 months were found between
the two groups.
4. Discussion
TCC is said to have both physiological and psychosocial beneﬁts
on individuals. Lan et al4 demonstrated that a 12-month TCC
program was effective in improving cardiorespiratory function,
muscle strength, and ﬂexibility in the elderly. Similarly, Hong et al19
reported that long-term regular TCC exercise had favorable effects
on the promotion of balance control, ﬂexibility, and cardiovascular
ﬁtness in the elderly. In addition, Lai et al3 studied 2-year trends in
cardiovascular function among elderly TCC practitioners and
sedentary individuals, and found that practicing TCC regularly may
delay the decline of cardiorespiratory function in older individuals.
In this study, we found that the FEV1/FVC of the TCC trainees was
increased signiﬁcantly after 3 months of TCC training. Our obser-
vation is in accordance with the ﬁnding of previous studies, where
TCC has been found to have beneﬁcial effects on the cardiorespi-
ratory function of the participants3,4,19.
Tsai et al20 showed that TCC training can decrease blood pres-
sure and result in favorable lipid proﬁle changes and improve thehs of TCC training.
TCC trainees (before training)
(n¼ 25)
TCC trainees (after training)
(n¼ 25)
89 (81w 94) 96 (93w 104)y
123 (87w 162) 95 (69w 161)
206 (180w 235) 191 (165w 205)y
127 (106w 158) 144 (114w 158)
54 (43w 64) 55 (45w 63)#
4.15 (3.46w 5.00) 3.53 (3.00w 4.23)y
2.66 (2.28w 3.19) 2.67 (2.34w 3.18)
5.1 (4.5w 7.0) 5.6 (4.5w 6.6)
7.9 (6.5w 12.9)A 16.2 (13.4w 19.3)y
0.38 (0.32w 0.43)* 0.96 (0.73w 1.30)Ay
ng; y p< 0.001 versus before TCC training.
e ratio of HDL-C over TC; LDL-C¼ low-density lipoprotein-cholesterol; TC¼ total
gamma; UA¼ uric acid.
Table 4
Percentage changes in general characteristics, spirometry and hemodynamics of the
controls and TCC trainees.
Characteristics Controls TCC trainees
Body weight (%) 0.00 (0.00w 0.79) 0.00 (0.00w 0.00)*
BMI (%) 0.00 (0.00w 0.79) 0.00 (0.00w 0.00)*
FVC (%) 0.00 (e4.56w 0.00) 0.04 (6.68w 4.01)
%FVC (%) 0.00 (1.12w 1.18) 1.14 (6.05w 4.13)
FEV1 (%) 0.00 (0.00w 0.00) 3.49 (1.83w 7.13)*
%FEV (%) 0.00 (0.00w 0.51) 3.41 (1.29w 7.87)
FEV1/FVC (%) 0.52 (0.46w 4.65) 3.75 (1.22w 9.57)
SBP (%) 0.68 (0.00w 6.56) 0.82 (10.53w 4.94)
DBP (%) 0.00 (3.16w 6.52) 4.29 (8.19w 9.08)
MABP (%) 2.60 (0.20w 5.41) 0.85 (9.55w 5.55)
PP (%) 1.72 (6.81w 20.68) 6.25 (15.71w 7.04)
Data are presented as median (25 percentilew 75 percentile).
*p< 0.05 versus controls.
Tai Chi Chuan Effect on Blood Lipids and Cytokines 271anxiety status of individuals. Tsai et al21 suggested that after 12
weeks of exercise and training in mild hypertensive patients,
a successful reduction in blood pressure and favorable changes of
lipid proﬁle can be noted. Yeh et al22 reported that Tai Chi exercise
may be a beneﬁcial adjunctive therapy for some patients with
cardiovascular disease (CVD) and CVD risk factors. Arsenault et al 23
also demonstrated that the TC/HDL-C, apoB/apoA-I and LDL/HDL
ratios were similarly associated with components of the metabolic
syndrome and coronary heart disease risk. In this study, we found
that HDL-C increased signiﬁcantly and TC was decreased signiﬁ-
cantly after 3 months of TCC training. Thus, the ratio TC/HDL-C
decreased signiﬁcantly after 3 months of TCC training, in accor-
dance with the results of the aforementioned studies20e23.
In this study, a higher level of blood glucosewas observed after 3
months of TCC training compared to that before TCC training,
although the blood glucose level after 3 months of TCC was still
within normal ranges. The increased glucose level after 3months of
TCC suggested that the glucose availability was increased by 3
months of TCC exercise. The mechanism underlying the increasedTable 5
Percentage changes in HRV measures, blood biochemistry, lipid proﬁle and cytokine
levels of the controls and TCC trainees.
Measures Controls TCC trainees
Time domain HRV
Mean RRI (%) 0.0 (4.9w 6.7) 5.0 (14.5w 5.4)
Heart rate (%) 0.9 (5.3w 0.3) 5.2 (5.1w 17.0)
SDRR (%) 0.6 (14.6w 8.9) 7.9 (32.3w 30.3)
CVRR (%) 0.0 (11.4w 8.0) 3.1 (24.2w 32.3)
Frequency domain HRV
TP (%) 0.0 (25.8w 31.4) 21.5 (48.2w 69.6)
VLFP (%) 0.0 (52.5w 53.9) 9.1 (44.1w 48.8)
LFP (%) 4.2 (7.0w 27.9) 31.6 (50.1w 87.7)
HFP (%) 0.0 (19.4w 13.0) 31.9 (65.0w 94.3)
nHFP (%) 7.3 (17.8w 66.9) 7.5 (43.3w 49.9)
nLFP (%) 5.9 (11.9w 41.1) 12.8 (32.3w 46.0)
nVLFP (%) 3.5 (31.9w 31.6) 1.2 (29.9w 66.6)
LFP/HFP (%) 13.4 (37.3w 9.4) 10.5 (46.0w 122.2)
Blood tests
FBS (%) 3.1 (5.0w 11.1) 10.4 (7.6w 15.0)*
TG (%) 5.3 (22.9w 21.4) 8.0 (27.0w 26.8)
TC (%) 0.6 (2.3w 2.8) 10.6 (13.7w4.8)y
LDL-C (%) 0.5 (0.0w 4.9) 3.6 (1.6w 12.5)
HDL-C (%) 0.0 (0.4w 4.3) 2.9 (2.4w 9.5)
TC/HDL-C (%) 1.0 (4.2w 1.4) 11.9 (18.4w6.8)y
LDL-C/HDL-C (%) 0.0 (3.4w 4.9) 3.9 (4.3w11.2)
UA (%) 0.0 (0.0w 0.0) 7.2 (8.7w15.3)
TNF-a (%) 0.0 (0.0w 4.6) 96.8 (5.6w 162.6)y
IFN-g (%) 0.0 (0.0w 16.9) 137.8 (109.3w 185.9)y
Data are presented as medians (25 percentilew 75 percentile).
*p< 0.05 versus controls; y p< 0.001 versus controls.glucose availability might be that exercise can suppress insulin
secretion, by increasing sympathetic tone at the pancreatic islets
after regular exercise24. Since glucose is the major source of energy
in the body, and since the store of readily available glucose to
supply the tissues with an oxidizable energy source is found prin-
cipally in the liver as glycogen, the increased level of blood glucose
in the TCC trainees might come from the glycogen stores of the
liver, where up to 10% of its weight is glycogen.
Chiang et al25 reported that the capacity of endurance athletes
to activate anti-leukemic immunity is signiﬁcantly higher than that
of sedentary controls and that the levels of human TNF-a and
human IFN-g in PHA-MNC (mononuclear)-CM (conditioned media)
were much higher in the athletic group when compared to the
controls. Zhang26 also showed that the practice of TCC for 2 months
signiﬁcantly increased the level of IgG in men, and signiﬁcantly
decreased the level of IgM in women. Li and Shen27 demonstrated
that the number and activity of natural killer cells in the peripheral
blood was signiﬁcantly increased after the practice of Wu’s TCC in
eight male TCC masters. Sun28 demonstrated that the total number
of circulating T cells, including active T lymphocytes, was signiﬁ-
cantly higher in the TCC practitioners than in the untrained group.
Yeh et al10 showed that regular TCC exercise promoted regulatory T
cells and its mediators, improved balance, increased physical
mobility, and enhanced the perceived beneﬁts of health in middle
aged adults. Yeh et al11 demonstrated that a regular TCC exercise
could increase CD4CD25 regulatory T-lymphocytes in type 2 dia-
betic patients. Similar to these studies, we found that 3 months of
TCC could increase the serum levels of TNF-a and IFN-g in TCC
trainees. This effect of 3 months of TCC training on the increase in
TNF-a and IFN-g might be related to a better cardiopulmonary
ﬁtness and plasma lipid proﬁle after TCC. Since TNF-a has impor-
tant functions of antitumor activity, growth regulation, immuno-
modulation, and proinﬂammation29, and since IFN-g plays an
important role in the growth and differentiation of cytotoxic (and
possibly suppressor) T cells, activates NK cells and acts as a B cell
maturation factor30, the increase in the levels of TNF-a and IFN-g
after 3 months of TCC training suggested that regular TCC exercise
might beneﬁt, not only cardiorespiratory function, but also
immunoregulatory function of the individuals.
Malave et al7 pointed out that there was a signiﬁcant inverse
linear correlation between increased circulating levels of TNF, TNF
receptors, and norepinephrine for time-domain and frequency-
domain indexes of HRV, among patients with heart failure and
control subjects. On the contrary, we found no correlation between
HRV measure and TNF-a in TCC trainees and the controls. The
reason for the different results between our study and that of
Malave et al might be that different study participants were used in
different studies. Further research in this regard is required.
Table 2 shows that there was a slight increase in the HFP after 3
months of TCC, while Table 5 shows that there was no signiﬁcant
difference in the % change in HFP between controls and TCC
trainees after 3 months of TCC. Since the nHFP was not changed
after 3 months of TCC, according to either Table 2 or Table 5, it
seems that the vagal modulation of the TCC trainees was not
changed after 3 months of TCC training.
The use of an objective measure of physical health and ﬁtness is
a major strength of this study, as it provides a more precise and
accurate estimate than some report of the level in the TCC exercise.
The detailed measures available allowed us to test for associations
of potential determinants such as cardiopulmonary function and
immune activity in the TCC program and to explore the role of
potential confounders in the physical activity of sport medicine. It is
worth mentioning that 20/25 participants in the TCC group (80%)
and 18/25 participants in the control group (72%) had minor
discomforts such as backache and lassitude before TCC training. No
W.-A. Lu, C.-D. Kuo272signiﬁcance in the number of participants with minor discomforts
and non-discomforts was found between these 2 groups (p¼ 0.741,
Chi-square test). Only ﬁve participants (20%) in the TCC group and 7
participants (18%) in the control group participated in this TCC
study, simply because of their interest in this renowned calis-
thenics. These minor discomforts were the motivation of some
individuals that drove them to participate in this study, for the sake
of health and ﬁtness. The presence of minor discomforts in slightly
more TCC trainees in the TCC group before TCC training might
contribute to the result that TCC trainees had signiﬁcantly lower
levels of TNF-a and IFN-g before TCC training, as compared to the
control group. It is interesting to note that serum levels of TNF-
a and IFN-g were signiﬁcantly increased after 3 months of TCC in
these TCC trainees. In this sense, TCC is indeed the calisthenics of
choice for those people who have minor discomforts and are
seeking some kinds of exercise to improve their health.
In conclusion, 3 months of TCC training can improve the
pulmonary function, glucose availability, blood lipid proﬁle, and
increase cytokine production in middle-aged and elderly individ-
uals. TCCmight be a good health-promoting calisthenics that can be
recommended to middle-aged and elderly people.
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